Condition
Acute Spinal Cord Injury (SCI)
Total Trials
6
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 1 (2)
P 3 (1)
Trial Status
Recruiting3
Not Yet Recruiting2
Unknown1
Clinical Trials (6)
Showing 6 of 6 trials
NCT07733401Not ApplicableNot Yet Recruiting
Guided Laminectomy With Augmented Duroplasty for Acute Traumatic Spinal Cord Injury
NCT07722962Phase 3Not Yet RecruitingPrimary
Additional Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury
NCT07090473Not ApplicableRecruitingPrimary
Safety of Transcutaneous Electrical Stimulation Potentiating Recovery in Acute Spinal Cord Injury Syndromes
NCT04278235UnknownPrimary
Expanded Access to Elezanumab
NCT06677229Phase 1RecruitingPrimary
Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord Injury
NCT06817577Phase 1RecruitingPrimary
NG004 in Spinal Cord Injury Patients
Showing all 6 trials